Synthesis and biological activity of some new flavonyl-2,4-thiazolidinediones

Bioorganic & Medicinal Chemistry
2008.0

Abstract

A new series of flavonyl-2,4-thiazolidinediones (Va-c, VIa-c) was prepared by Knoevenagel reaction. The synthesized compounds were tested for their ability to inhibit rat kidney aldose reductase (AR) and for their insulinotropic activities in INS-1 cells. Compound Vb was able to increase insulin release in the presence of 5.6mmol/l glucose. Compounds VIa-c displayed moderate to high AR inhibitory activity levels. Particularly, compound VIa showed the highest AR inhibitory activity (86.57%).

Knowledge Graph

Similar Paper

Synthesis and biological activity of some new flavonyl-2,4-thiazolidinediones
Bioorganic & Medicinal Chemistry 2008.0
3-Aryl-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)phenoxy]-phenyl}-acrylic acid alkyl ester: synthesis and antihyperglycemic evaluation
Medicinal Chemistry Research 2011.0
Synthesis, α-glucosidase inhibition and molecular docking studies of novel thiazolidine-2,4-dione or rhodanine derivatives
MedChemComm 2017.0
Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5′-imidazolidine]-2′,4′-diones
European Journal of Medicinal Chemistry 2015.0
Synthesis and antihyperglycemic evaluation of new 2,4-thiazolidinediones having biodynamic aryl sulfonylurea moieties
Bioorganic & Medicinal Chemistry Letters 2012.0
Molecular Design, Synthesis, and Hypoglycemic Activity of a Series of Thiazolidine-2,4-diones
Journal of Medicinal Chemistry 2000.0
Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents
Journal of Medicinal Chemistry 1992.0
Novel 5-Substituted 2,4-Thiazolidinedione and 2,4-Oxazolidinedione Derivatives as Insulin Sensitizers with Antidiabetic Activities
Journal of Medicinal Chemistry 2002.0
Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring
European Journal of Medicinal Chemistry 2013.0
Synthesis of new arylsulfonylspiroimidazolidine-2ʹ,4ʹ-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress
European Journal of Medicinal Chemistry 2019.0